世界の肝炎マーカー検査市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV12172)
◆英語タイトル:Global Hepatitis Marker Testing Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV12172
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:90
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは肝炎マーカー検査の世界市場について調査・分析した資料です。種類別(A型肝炎、B型肝炎、C型肝炎、D型肝炎)の市場規模、用途別(診断センター、病院)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別肝炎マーカー検査の競争状況、市場シェア
・世界の肝炎マーカー検査市場:種類別市場規模 2015年-2020年(A型肝炎、B型肝炎、C型肝炎、D型肝炎)
・世界の肝炎マーカー検査市場:種類別市場規模予測 2021年-2026年(A型肝炎、B型肝炎、C型肝炎、D型肝炎)
・世界の肝炎マーカー検査市場:用途別市場規模 2015年-2020年(診断センター、病院)
・世界の肝炎マーカー検査市場:用途別市場規模予測 2021年-2026年(診断センター、病院)
・北米の肝炎マーカー検査市場分析:米国、カナダ
・ヨーロッパの肝炎マーカー検査市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの肝炎マーカー検査市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の肝炎マーカー検査市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの肝炎マーカー検査市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Becton, Dickinson、Beckman Coulter、Cepheid、BioMérieux、Bio-Rad Laboratories、Siemens Healthcare、QIAGEN、F. Hoffmann La–Roche、Hologic、Thermo Fisher Scientific
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

The liver is an essential organ of the body which helps in digestion of food, removal of toxins from the blood, and storage of energy in the body. Inflammation of the liver usually due to viral infections, excessive alcohol consumption, and drugs can cause hepatitis. Hepatitis can be classified as hepatitis A, hepatitis B, hepatitis C, hepatitis D, and hepatitis E through laboratory testing. Acute infection may occur with no symptoms or limited symptoms such as jaundice, dark urine, nausea, extreme fatigue, vomiting, and abdominal pain. People suffering from hepatitis are tested with a range of markers depending on the symptoms exhibited, clinical history, and other tests.

Market Analysis and Insights: Global Hepatitis Marker Testing Market
The global Hepatitis Marker Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Hepatitis Marker Testing Scope and Market Size
Hepatitis Marker Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis Marker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Becton, Dickinson
Beckman Coulter
Cepheid
BioMérieux
Bio-Rad Laboratories
Siemens Healthcare
QIAGEN
F. Hoffmann La–Roche
Hologic
Thermo Fisher Scientific

Market segment by Type, the product can be split into
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Market segment by Application, split into
Diagnostic Centers
Hospitals

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hepatitis Marker Testing Revenue
1.4 Market by Type
1.4.1 Global Hepatitis Marker Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hepatitis A
1.4.3 Hepatitis B
1.4.4 Hepatitis C
1.4.5 Hepatitis D
1.5 Market by Application
1.5.1 Global Hepatitis Marker Testing Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic Centers
1.5.3 Hospitals
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Hepatitis Marker Testing Market Perspective (2015-2026)
2.2 Global Hepatitis Marker Testing Growth Trends by Regions
2.2.1 Hepatitis Marker Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hepatitis Marker Testing Historic Market Share by Regions (2015-2020)
2.2.3 Hepatitis Marker Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hepatitis Marker Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Hepatitis Marker Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Hepatitis Marker Testing Players by Market Size
3.1.1 Global Top Hepatitis Marker Testing Players by Revenue (2015-2020)
3.1.2 Global Hepatitis Marker Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Hepatitis Marker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hepatitis Marker Testing Market Concentration Ratio
3.2.1 Global Hepatitis Marker Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hepatitis Marker Testing Revenue in 2019
3.3 Hepatitis Marker Testing Key Players Head office and Area Served
3.4 Key Players Hepatitis Marker Testing Product Solution and Service
3.5 Date of Enter into Hepatitis Marker Testing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Hepatitis Marker Testing Historic Market Size by Type (2015-2020)
4.2 Global Hepatitis Marker Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Hepatitis Marker Testing Market Size by Application (2015-2020)
5.2 Global Hepatitis Marker Testing Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Hepatitis Marker Testing Market Size (2015-2020)
6.2 Hepatitis Marker Testing Key Players in North America (2019-2020)
6.3 North America Hepatitis Marker Testing Market Size by Type (2015-2020)
6.4 North America Hepatitis Marker Testing Market Size by Application (2015-2020)

7 Europe
7.1 Europe Hepatitis Marker Testing Market Size (2015-2020)
7.2 Hepatitis Marker Testing Key Players in Europe (2019-2020)
7.3 Europe Hepatitis Marker Testing Market Size by Type (2015-2020)
7.4 Europe Hepatitis Marker Testing Market Size by Application (2015-2020)

8 China
8.1 China Hepatitis Marker Testing Market Size (2015-2020)
8.2 Hepatitis Marker Testing Key Players in China (2019-2020)
8.3 China Hepatitis Marker Testing Market Size by Type (2015-2020)
8.4 China Hepatitis Marker Testing Market Size by Application (2015-2020)

9 Japan
9.1 Japan Hepatitis Marker Testing Market Size (2015-2020)
9.2 Hepatitis Marker Testing Key Players in Japan (2019-2020)
9.3 Japan Hepatitis Marker Testing Market Size by Type (2015-2020)
9.4 Japan Hepatitis Marker Testing Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Hepatitis Marker Testing Market Size (2015-2020)
10.2 Hepatitis Marker Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hepatitis Marker Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Hepatitis Marker Testing Market Size by Application (2015-2020)

11 India
11.1 India Hepatitis Marker Testing Market Size (2015-2020)
11.2 Hepatitis Marker Testing Key Players in India (2019-2020)
11.3 India Hepatitis Marker Testing Market Size by Type (2015-2020)
11.4 India Hepatitis Marker Testing Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Hepatitis Marker Testing Market Size (2015-2020)
12.2 Hepatitis Marker Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Hepatitis Marker Testing Market Size by Type (2015-2020)
12.4 Central & South America Hepatitis Marker Testing Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Becton, Dickinson
13.1.1 Becton, Dickinson Company Details
13.1.2 Becton, Dickinson Business Overview
13.1.3 Becton, Dickinson Hepatitis Marker Testing Introduction
13.1.4 Becton, Dickinson Revenue in Hepatitis Marker Testing Business (2015-2020))
13.1.5 Becton, Dickinson Recent Development
13.2 Beckman Coulter
13.2.1 Beckman Coulter Company Details
13.2.2 Beckman Coulter Business Overview
13.2.3 Beckman Coulter Hepatitis Marker Testing Introduction
13.2.4 Beckman Coulter Revenue in Hepatitis Marker Testing Business (2015-2020)
13.2.5 Beckman Coulter Recent Development
13.3 Cepheid
13.3.1 Cepheid Company Details
13.3.2 Cepheid Business Overview
13.3.3 Cepheid Hepatitis Marker Testing Introduction
13.3.4 Cepheid Revenue in Hepatitis Marker Testing Business (2015-2020)
13.3.5 Cepheid Recent Development
13.4 BioMérieux
13.4.1 BioMérieux Company Details
13.4.2 BioMérieux Business Overview
13.4.3 BioMérieux Hepatitis Marker Testing Introduction
13.4.4 BioMérieux Revenue in Hepatitis Marker Testing Business (2015-2020)
13.4.5 BioMérieux Recent Development
13.5 Bio-Rad Laboratories
13.5.1 Bio-Rad Laboratories Company Details
13.5.2 Bio-Rad Laboratories Business Overview
13.5.3 Bio-Rad Laboratories Hepatitis Marker Testing Introduction
13.5.4 Bio-Rad Laboratories Revenue in Hepatitis Marker Testing Business (2015-2020)
13.5.5 Bio-Rad Laboratories Recent Development
13.6 Siemens Healthcare
13.6.1 Siemens Healthcare Company Details
13.6.2 Siemens Healthcare Business Overview
13.6.3 Siemens Healthcare Hepatitis Marker Testing Introduction
13.6.4 Siemens Healthcare Revenue in Hepatitis Marker Testing Business (2015-2020)
13.6.5 Siemens Healthcare Recent Development
13.7 QIAGEN
13.7.1 QIAGEN Company Details
13.7.2 QIAGEN Business Overview
13.7.3 QIAGEN Hepatitis Marker Testing Introduction
13.7.4 QIAGEN Revenue in Hepatitis Marker Testing Business (2015-2020)
13.7.5 QIAGEN Recent Development
13.8 F. Hoffmann La–Roche
13.8.1 F. Hoffmann La–Roche Company Details
13.8.2 F. Hoffmann La–Roche Business Overview
13.8.3 F. Hoffmann La–Roche Hepatitis Marker Testing Introduction
13.8.4 F. Hoffmann La–Roche Revenue in Hepatitis Marker Testing Business (2015-2020)
13.8.5 F. Hoffmann La–Roche Recent Development
13.9 Hologic
13.9.1 Hologic Company Details
13.9.2 Hologic Business Overview
13.9.3 Hologic Hepatitis Marker Testing Introduction
13.9.4 Hologic Revenue in Hepatitis Marker Testing Business (2015-2020)
13.9.5 Hologic Recent Development
13.10 Thermo Fisher Scientific
13.10.1 Thermo Fisher Scientific Company Details
13.10.2 Thermo Fisher Scientific Business Overview
13.10.3 Thermo Fisher Scientific Hepatitis Marker Testing Introduction
13.10.4 Thermo Fisher Scientific Revenue in Hepatitis Marker Testing Business (2015-2020)
13.10.5 Thermo Fisher Scientific Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Becton, Dickinson、Beckman Coulter、Cepheid、BioMérieux、Bio-Rad Laboratories、Siemens Healthcare、QIAGEN、F. Hoffmann La–Roche、Hologic、Thermo Fisher Scientific

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の肝炎マーカー検査市場2026:インサイト・予測(Global Hepatitis Marker Testing Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。